Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Esophageal Neoplasms × durvalumab × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrent Squamous Cell Lung Carcinoma 3 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Solid Malignancies 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Cancer Metastatic 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Rare Tumours 1

Interventions

Radiotherapy 7 Fluorouracil 7 Cisplatin 7 Paclitaxel 6 Oxaliplatin 6 Irinotecan 5 Leucovorin 4 Cetuximab 4 Docetaxel 3 Surgical Procedures, Operative 2 Polymerase Chain Reaction 2 Capecitabine 2 uridine triacetate 1 durvalumab 1 carfilzomib 1 Taxes 1 Sorafenib 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Preoperative Exercise 1 Platinum 1 Lithium 1 Gene Expression Profiling 1 Gemcitabine 1 Folfox protocol 1 Filgrastim 1 Epirubicin 1 Chemotherapy, Adjuvant 1 Carboplatin 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06290505 2025-07-23

PALEO

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡